Soru

The following passage discusses legal frameworks and intellectual property rights related to bioprospecting.

In the latter half of the twentieth century, the acceleration of bioprospecting—the exploration of biodiversity for commercially valuable genetic and biochemical resources—precipitated complex debates regarding intellectual property rights (IPR) and indigenous knowledge. Historically, the legal framework governing these resources was predicated on the doctrine of *res nullius*, or the "common heritage of mankind," which posited that uncultivated biological resources were globally shared public goods. This paradigm, vigorously defended by legal scholar Annelise R. Pistor in the 1980s, argued that genetic resources, existing in a state of nature, could not be subject to sovereign ownership, thereby facilitating unhindered access for pharmaceutical and agricultural corporations. Pistor’s framework, however, drew a sharp distinction between the raw genetic material (the common heritage) and the modified, synthesized derivatives, which she maintained were rightfully patentable due to the application of human ingenuity.

Conversely, by the early 1990s, developing nations enriched with biodiversity challenged this open-access regime, culminating in the 1992 Convention on Biological Diversity (CBD). The CBD fundamentally altered the international legal landscape by replacing the common heritage principle with the doctrine of sovereign rights, granting states authority over their biological resources. While the CBD established a framework for access and benefit-sharing (ABS), it was heavily criticized by indigenous rights advocate Marcus T. Velloso. Velloso contended that the CBD merely transferred the locus of expropriation from international corporations to state governments, failing to recognize the customary rights of indigenous communities who had cultivated and preserved these resources for millennia. He argued that the state-centric approach of the CBD effectively marginalized indigenous knowledge systems, treating traditional ecological knowledge as a secondary, non-proprietary input.

Building upon Velloso's critique, contemporary legal theorist Elena K. Rostova proposed a "sui generis" (unique) legal framework in the early 2000s, designed specifically to protect traditional knowledge outside the conventional patent system. Rostova asserted that traditional IPR mechanisms, such as patents, are fundamentally incompatible with indigenous knowledge because patents require a clearly identifiable inventor, a discrete act of invention, and an expiration date. In contrast, indigenous knowledge is often collectively held, transgenerational, and incrementally developed. Rostova’s model advocated for the recognition of "community intellectual rights," which would grant perpetual protection and require prior informed consent directly from the indigenous groups, bypassing state intermediaries altogether.

Complicating this discourse further, economic historian Julian F. Vance analyzed the practical implementation of ABS agreements under both the CBD and subsequent national laws. In his comprehensive 2015 study, Vance found that even when indigenous communities were granted direct negotiation rights, the extreme asymmetry in legal expertise and market information between these communities and multinational corporations consistently resulted in inequitable agreements. Vance concluded that without mandatory, international minimum standards for compensation and standardized disclosure of origin requirements, any localized legal framework—whether state-centric or sui generis—would remain vulnerable to exploitation by well-resourced pharmaceutical entities.

Match each scholar or theorist mentioned in the passage with the specific argument or observation they advanced.